Modelling the impact of population-based cytologic screening on cervical cancer incidence and mortality in Hong Kong: an age|[ndash]|period|[ndash]|cohort approach

摘要

Cervical cancer incidence and mortality statistics in Hong Kong during 1972–2001 were examined to estimate the potential number of cancer cases that can be averted and years of life saved after the launch of an organised, population-based cytologic screening recall programme in 2004 with projections to 2016. Incidence rates under the status quo of opportunistic screening were projected by an age–period–cohort model, using maximum likelihood and Bayesian methods. Modelled rates were translated into numbers of cancer cases and deaths using mid-year population figures and age–period-specific mortality to incidence ratios. We applied International Agency for Research on Cancer risk reduction estimates for different screening strategies to these base case figures to estimate the number of incident cancers potentially averted and years of life saved attributable to organised screening incremental to the current status quo. The estimated numbers of cases projected to be preventable by the maximum likelihood (Bayesian) approach from 2002 to 2016 were 4226 (4176), 3778 (3728) and 2334 (2287) with organised screening every 1, 3 and 5 years, compared to haphazard screening currently. Correspondingly, 33?000 (32?800), 29?500 (29?300) and 18?200 (17?900) years of life could potentially be saved.